Wellcome Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$434M Hold
4,800,000
4.82% 11
2026
Q1
$384M Hold
4,800,000
4.75% 12
2025
Q4
$409M Hold
4,800,000
4.39% 11
2025
Q3
$373M Hold
4,800,000
4.06% 13
2025
Q2
$375M Hold
4,800,000
4.33% 11
2025
Q1
$348M Hold
4,800,000
4.35% 10
2024
Q4
$355M Buy
4,800,000
+300,000
+7% +$21M 4.29% 10
2024
Q3
$297M Buy
4,500,000
+400,000
+10% +$29.1M 3.62% 16
2024
Q2
$379M Hold
4,100,000
4.84% 9
2024
Q1
$392M Hold
4,100,000
4.71% 8
2023
Q4
$313M Buy
4,100,000
+590,000
+17% +$41.1M 3.87% 13
2023
Q3
$243M Buy
3,510,000
+2,860,000
+440% +$230M 3.23% 17
2023
Q2
$61.3M Hold
650,000
0.81% 21
2023
Q1
$53.8M Hold
650,000
0.75% 21
2022
Q4
$48.5M Buy
650,000
+325,000
+100% +$25M 0.72% 22
2022
Q3
$26.9M Buy
+325,000
New +$31.3M 0.42% 22

Other funds holding EW